Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1983-09-09
1986-02-04
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514538, 514542, 514555, 514562, 260465D, 26050112, 560 10, 562427, A61K 31275
Patent
active
045686939
ABSTRACT:
Herein disclosed are N-naphthoylglycine derivatives having aldose reductase inhibiting activity. The derivatives are useful for treating diabetic complications.
REFERENCES:
patent: 3821383 (1974-06-01), Sestanj et al.
patent: 4391816 (1983-07-01), Sestanj
patent: 4391825 (1983-07-01), Bellini
D. Dvornik et al., Science, 182, 1146 (1973).
M. J. Peterson et al., Metabolism, 28 (Suppl. 1), 456 (1979).
A. Lawson and C. E. Searle, J. Chem. Soc., 1556 (1957).
V. I. Cohen et al., Eur. J. Med. Chem., 5, 480 (1976); see also Chem. Abstr., 86, 189582f (1977).
J. Voss and W. Walter, Justus Leibigs Ann. Chem., 716, 209 (1968); see also Chem. Abstr.; 70, 11306a (1969).
Chem. Abstr., 61, 4333f (1964) for E. Cioranescu et al., Rev. Chim. Acad. Rep. Populaire Roumaine, 7 (2), 755 (1962).
Abraham Nedumparambil A.
Bellini Francesco
Sestanj Kazimir
Treasurywala Adi
Ayerst McKenna & Harrison, Inc.
Shippen Michael L.
Wilfond Arthur E.
LandOfFree
N-Naphthoylglycine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-Naphthoylglycine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Naphthoylglycine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2341200